Balsalazide Sodium Capsules

Balsalazide Sodium Capsules are a new type of 5-aminosalicylic acid prodrug. After oral administration, it enters the colon in its original form, minimizing systemic adverse reactions. Balsalazide Sodium Capsules induce chemotaxis of polymorphonuclear leukocytes, inhibit lipoxygenase, lead to reduced leukotriene release and inhibit macrophage migration, and are therefore the first choice for intestinal anti-inflammatory drugs. Balsalazide Sodium Capsules were jointly developed by the First Affiliated Hospital of China Medical University, the First Hospital of Jilin University, the General Hospital of Tianjin Medical University and the Second Affiliated Hospital of Zhengzhou University as a national Class II new drug.

Inflammatory bowel disease (mild to moderate ulcerative colitis, chronic amoebiasis, Crohn's disease)

Adults: Take 4 capsules each time, three times a day until relief, for up to 12 weeks. Not recommended for children.

Keep away from light and store in airtight container.

375mg

Chifeng Mysun Pharmaceutical Co., Ltd.

• Founded in:

  2001-11-28

• Address:

  No. 1, Mengxin Street, Hongshan Economic Development Zone, Chifeng

• Tax NO.:

  91150402114795518Q

• Registered Funds:

  44.22 million yuan

• Email:

  Log in to view